The Law of Chemical, Metallurgical and Pharmaceutical PatentsHoward I. Forman Central Book Company, 1967 - 863 lappuses |
No grāmatas satura
1.–3. rezultāts no 74.
279. lappuse
... effect , of course , there should be a very thorough treatment of the effect in your specification . Because , as we have discussed already , if you don't have this disclosure , this spelling out of the synergistic effect , then you can ...
... effect , of course , there should be a very thorough treatment of the effect in your specification . Because , as we have discussed already , if you don't have this disclosure , this spelling out of the synergistic effect , then you can ...
530. lappuse
... effect on established industry , the supply of raw materials , the material for new products to be used in carrying out the new invention , the effect on industries other than those which at first glance seemed to be directly affected ...
... effect on established industry , the supply of raw materials , the material for new products to be used in carrying out the new invention , the effect on industries other than those which at first glance seemed to be directly affected ...
618. lappuse
... effect of 0.4 and there was a true equivalence , the court in view of all of that evidence had no great difficulty ... effect of the 1 : 1 , and not the effect of the prior art . If , say , the prior art had a 5 : 1 ratio and this is 32 ...
... effect of 0.4 and there was a true equivalence , the court in view of all of that evidence had no great difficulty ... effect of the 1 : 1 , and not the effect of the prior art . If , say , the prior art had a 5 : 1 ratio and this is 32 ...
Saturs
Chapter | 1 |
By CHARLES C PRICE | 15 |
By JOHN T CONNOR AND I LOUIS WOLK | 25 |
Autortiesības | |
15 citas sadaļas nav parādītas.
Bieži izmantoti vārdi un frāzes
2nd Cir affidavit alloy assignment basis Board of Appeals chemical compound chemical patent chromium claims Company considered Corp court held Court of Customs Customs and Patent decision diligence disclosed discovery discussed doctrine of equivalents double patenting drug effect estoppel Examiner example fact filing date granted industry infringement ingredients interference interference proceedings invalid inventor inventorship involved issue license licensor limited machine manufacture Markush material ment method motion obtain obvious party Patent Act Patent Appeals patent application Patent Attorney Patent Examining patent law Patent Office patent system patented invention pharmaceutical present printed publication prior art priority problem proof properties question reason reduction to practice reference reissue rejection result royalty Rule Section 103 situation skilled SOC'Y specification statement statute statutory steel subject matter supra thing tion U.S. Patent United unobvious vention